164 related articles for article (PubMed ID: 36193835)
1. Role and effectiveness of progestins in pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and a meta-analysis.
Yildiz S; Turkgeldi E; Ata B
Minerva Obstet Gynecol; 2023 Dec; 75(6):573-582. PubMed ID: 36193835
[TBL] [Abstract][Full Text] [Related]
2. Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses.
Ata B; Capuzzo M; Turkgeldi E; Yildiz S; La Marca A
Hum Reprod Update; 2021 Jan; 27(1):48-66. PubMed ID: 33016316
[TBL] [Abstract][Full Text] [Related]
3. Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis.
Alexandru P; Cekic SG; Yildiz S; Turkgeldi E; Ata B
Reprod Biomed Online; 2020 Jun; 40(6):894-903. PubMed ID: 32327297
[TBL] [Abstract][Full Text] [Related]
4. Progestin-Primed Ovarian Stimulation Protocol for Patients in Assisted Reproductive Technology: A Meta-Analysis of Randomized Controlled Trials.
Guan S; Feng Y; Huang Y; Huang J
Front Endocrinol (Lausanne); 2021; 12():702558. PubMed ID: 34531825
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.
Kalafat E; Turkgeldi E; Yıldız S; Dizdar M; Keles I; Ata B
Front Endocrinol (Lausanne); 2022; 13():837880. PubMed ID: 35663329
[TBL] [Abstract][Full Text] [Related]
6. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
Kadoura S; Alhalabi M; Nattouf AH
Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
[TBL] [Abstract][Full Text] [Related]
8. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing
Yang L; Liang F; Yuan Y; Luo X; Wang Q; Yao L; Zhang X
Front Endocrinol (Lausanne); 2023; 14():1224858. PubMed ID: 37795363
[TBL] [Abstract][Full Text] [Related]
10. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysis.
Cui L; Lin Y; Wang F; Chen C
Arch Gynecol Obstet; 2021 Mar; 303(3):615-630. PubMed ID: 33433705
[TBL] [Abstract][Full Text] [Related]
12. GnRH antagonist protocol versus progestin-primed ovarian stimulation in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Deng R; Wang J; He J; Lei X; Zi D; Nong W; Lei X
Arch Gynecol Obstet; 2024 Apr; 309(4):1151-1163. PubMed ID: 37957365
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study.
Chen H; Teng XM; Sun ZL; Yao D; Wang Z; Chen ZQ
Fertil Steril; 2022 Oct; 118(4):701-712. PubMed ID: 35940929
[TBL] [Abstract][Full Text] [Related]
14. Progestin-primed ovarian stimulation: for whom, when and how?
Ata B; Kalafat E
Reprod Biomed Online; 2024 Feb; 48(2):103639. PubMed ID: 38159467
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Cumulative Live Birth Rates Between Progestin and GnRH Analogues in Preimplantation Genetic Testing Cycles.
Zhou R; Dong M; Huang L; Wang S; Wang Z; Xu L; Zhang X; Liu F
J Clin Endocrinol Metab; 2023 Dec; 109(1):217-226. PubMed ID: 37450562
[TBL] [Abstract][Full Text] [Related]
16. New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology.
Iwami N; Kawamata M; Ozawa N; Yamamoto T; Watanabe E; Moriwaka O; Kamiya H
Arch Gynecol Obstet; 2018 Sep; 298(3):663-671. PubMed ID: 30069600
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.
Du M; Zhang J; Li Z; Liu X; Li J; Liu W; Guan Y
Front Endocrinol (Lausanne); 2021; 12():705264. PubMed ID: 34589055
[TBL] [Abstract][Full Text] [Related]
18. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
19. Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma.
Yang AM; Feng TF; Han Y; Zhao ZM; Wang W; Wang YZ; Zuo XQ; Xu X; Shi BJ; Li L; Hao GM; Cui N
Front Endocrinol (Lausanne); 2022; 13():798434. PubMed ID: 35574014
[TBL] [Abstract][Full Text] [Related]
20. What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis.
Venetis CA; Storr A; Chua SJ; Mol BW; Longobardi S; Yin X; D'Hooghe T
Hum Reprod Update; 2023 May; 29(3):307-326. PubMed ID: 36594696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]